Cisplatin, Metronomic Low-Dose Interferon Alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Pancreatic Cancer
Related studies linked through entity extraction aliases.
Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas
- Status
- UNKNOWN
- Phase
- NA
3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Tipifarnib and Radiation Therapy in Treating Patients With Unresectable Locally Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab With or Without Docetaxel in Treating Patients With Previously Treated Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Alanosine in Treating Patients With Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Perifosine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE3
ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study With LY293111, Gemcitabine and Placebo in Patients With Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2